content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <headerData>
  <submissionType>144</submissionType>
  <filerInfo>
  <filer>
  <filerCredentials>
  <cik>0001796224</cik>
  <ccc>XXXXXXXX</ccc>
  </filerCredentials>
  </filer>
  <liveTestFlag>LIVE</liveTestFlag>
  </filerInfo>
  </headerData>
  <formData>
  <issuerInfo>
  <issuerCik>0001479290</issuerCik>
  <issuerName>Revance Therapeutics, Inc.</issuerName>
  <secFileNumber>001-36297</secFileNumber>
  <issuerAddress>
  <street1 xmlns="http://www.sec.gov/edgar/common">1222 Demonbreun St</street1>
  <street2 xmlns="http://www.sec.gov/edgar/common">Suite 2000</street2>
  <city xmlns="http://www.sec.gov/edgar/common">Nashville</city>
  <stateOrCountry xmlns="http://www.sec.gov/edgar/common">TN</stateOrCountry>
  <zipCode xmlns="http://www.sec.gov/edgar/common">37203</zipCode>
  </issuerAddress>
  <issuerContactPhone>615-724-7755</issuerContactPhone>
  <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Dustin Sjuts</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
  <relationshipsToIssuer>
  <relationshipToIssuer>Officer</relationshipToIssuer>
  </relationshipsToIssuer>
  </issuerInfo>
  <securitiesInformation>
  <securitiesClassTitle>Common</securitiesClassTitle>
  <brokerOrMarketmakerDetails>
  <name>Morgan Stanley Smith Barney LLC Executive Financial Services</name>
  <address>
  <street1 xmlns="http://www.sec.gov/edgar/common">1 New York Plaza 38th Floor</street1>
  <city xmlns="http://www.sec.gov/edgar/common">New York</city>
  <stateOrCountry xmlns="http://www.sec.gov/edgar/common">NY</stateOrCountry>
  <zipCode xmlns="http://www.sec.gov/edgar/common">10004</zipCode>
  </address>
  </brokerOrMarketmakerDetails>
  <noOfUnitsSold>9500</noOfUnitsSold>
  <aggregateMarketValue>52500</aggregateMarketValue>
  <noOfUnitsOutstanding>104500000</noOfUnitsOutstanding>
  <approxSaleDate>03/15/2024</approxSaleDate>
  <securitiesExchangeName>NASD</securitiesExchangeName>
  </securitiesInformation>
  <securitiesToBeSold>
  <securitiesClassTitle>Revance Common</securitiesClassTitle>
  <acquiredDate>03/15/2024</acquiredDate>
  <natureOfAcquisitionTransaction>RSU Vesting</natureOfAcquisitionTransaction>
  <nameOfPersonfromWhomAcquired>Revance Therapeutics</nameOfPersonfromWhomAcquired>
  <isGiftTransaction>N</isGiftTransaction>
  <amountOfSecuritiesAcquired>9500</amountOfSecuritiesAcquired>
  <paymentDate>03/15/2024</paymentDate>
  <natureOfPayment>Cash</natureOfPayment>
  </securitiesToBeSold>
  <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
  <remarks>Shares sold to cover taxes from a RSU vest</remarks>
  <noticeSignature>
  <noticeDate>03/18/2024</noticeDate>
  <signature>/s/ Dustin Sjuts</signature>
  </noticeSignature>
  </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 2821}]
text: 144
  0001796224
  XXXXXXXX
  LIVE
  0001479290
  Revance Therapeutics, Inc.
  001-36297
  1222 Demonbreun St
  Suite 2000
  Nashville
  TN
  37203
  615-724-7755
  Dustin Sjuts
  Officer
  Common
  Morgan Stanley Smith Barney LLC Executive Financial Services
  1 New York Plaza 38th Floor
  New York
  NY
  10004
  9500
  52500
  104500000
  03/15/2024
  NASD
  Revance Common
  03/15/2024
  RSU Vesting
  Revance Therapeutics
  N
  9500
  03/15/2024
  Cash
  Y
  Shares sold to cover taxes from a RSU vest
  03/18/2024
  /s/ Dustin Sjuts